Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Warts 2Virus Diseases 1Skin Diseases, Viral 1Skin Diseases, Infectious 1Skin Diseases 1Sexually Transmitted Diseases, Viral 1Sexually Transmitted Diseases 1Papillomavirus Infections 1Condylomata Acuminata 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Has results × Cantharidin × Clear all
NCT03981822 2024-11-27

CARE-1

Verrica Pharmaceuticals Inc.

Phase 2 Completed
105 enrolled 24 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Skin Diseases, Skin Diseases, Infectious, Virus Diseases, Warts, Sexually Transmitted Diseases, Viral, Skin Diseases, Viral, Papillomavirus Infections

NCT05070754 2024-04-05

Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca

Medical University of South Carolina

Phase 4 Completed
17 enrolled 13 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡